The National Institutes of Health has announced it was enrolling hundreds of people in phase 2 clinical trials that will evaluate at least four potential treatments for long COVID. The news ...

Extracorporeal haemoadsorption was primarily introduced as an adjunctive treatment option for sepsis 1 and is increasingly being used for critically ill patients with conditions related to ...

Share on Pinterest Can a new umbrella-definition of long COVID help healthcare providers diagnose the condition and suggest better treatment avenues? Image credit: The Washington Post/Getty Images A ...

Hypertension is a significant risk factor for cardiovascular diseases. The prevalence of hypertension and its complications is increasing yearly, yet it remains inadequately controlled worldwide. It ...